Ark Therapeutics Group PLC
Records under this name other than the patents Ark Therapeutics Group PLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 2 of 2 · Back to Ark Therapeutics Group PLC
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,003,679 | Use of Inhibitors of the Renin-Angiotensin System Term ended Term ended Oct 6, 2022 · Medium confidence | Term ended | Term ended Oct 6, 2022 | Medium confidence |
| US 7,998,953 | Use of inhibitors of the renin-angiotensin system Term ended Term ended Jun 6, 2020 · USPTO record | Term ended | Term ended Jun 6, 2020 | USPTO record |